122 related articles for article (PubMed ID: 17029785)
1. V180I mutation of the prion protein gene associated with atypical PrPSc glycosylation.
Chasseigneaux S; Haïk S; Laffont-Proust I; De Marco O; Lenne M; Brandel JP; Hauw JJ; Laplanche JL; Peoc'h K
Neurosci Lett; 2006 Nov; 408(3):165-9. PubMed ID: 17029785
[TBL] [Abstract][Full Text] [Related]
2. Loss of glycosylation associated with the T183A mutation in human prion disease.
Grasbon-Frodl E; Lorenz H; Mann U; Nitsch RM; Windl O; Kretzschmar HA
Acta Neuropathol; 2004 Dec; 108(6):476-84. PubMed ID: 15558291
[TBL] [Abstract][Full Text] [Related]
3. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
[TBL] [Abstract][Full Text] [Related]
4. The number of octapeptide repeat affects the expression and conversion of prion protein.
Hiraga C; Kobayashi A; Kitamoto T
Biochem Biophys Res Commun; 2009 May; 382(4):715-9. PubMed ID: 19318088
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of mono-glycosylated form-rich, plaque-forming PrPSc in the second atypical bovine spongiform encephalopathy case in Japan.
Hagiwara K; Yamakawa Y; Sato Y; Nakamura Y; Tobiume M; Shinagawa M; Sata T
Jpn J Infect Dis; 2007 Sep; 60(5):305-8. PubMed ID: 17881874
[TBL] [Abstract][Full Text] [Related]
6. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein.
Stöhr J; Elfrink K; Weinmann N; Wille H; Willbold D; Birkmann E; Riesner D
Biol Chem; 2011 May; 392(5):415-21. PubMed ID: 21476870
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
8. Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease.
Zanusso G; Polo A; Farinazzo A; Nonno R; Cardone F; Di Bari M; Ferrari S; Principe S; Gelati M; Fasoli E; Fiorini M; Prelli F; Frangione B; Tridente G; Bentivoglio M; Giorgi A; Schininà ME; Maras B; Agrimi U; Rizzuto N; Pocchiari M; Monaco S
Arch Neurol; 2007 Apr; 64(4):595-9. PubMed ID: 17420324
[TBL] [Abstract][Full Text] [Related]
9. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
[TBL] [Abstract][Full Text] [Related]
10. Altered prion protein glycosylation in the aging mouse brain.
Goh AX; Li C; Sy MS; Wong BS
J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
[TBL] [Abstract][Full Text] [Related]
11. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
12. Classification of sporadic Creutzfeldt-Jakob disease revisited.
Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
[TBL] [Abstract][Full Text] [Related]
13. Creutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene.
Capellari S; Cardone F; Notari S; Schininà ME; Maras B; Sità D; Baruzzi A; Pocchiari M; Parchi P
Neurology; 2005 Mar; 64(5):905-7. PubMed ID: 15753435
[TBL] [Abstract][Full Text] [Related]
14. Biochemical fingerprints of prion diseases: scrapie prion protein in human prion diseases that share prion genotype and type.
Pan T; Li R; Kang SC; Pastore M; Wong BS; Ironside J; Gambetti P; Sy MS
J Neurochem; 2005 Jan; 92(1):132-42. PubMed ID: 15606903
[TBL] [Abstract][Full Text] [Related]
15. Glycoform-selective prion formation in sporadic and familial forms of prion disease.
Xiao X; Yuan J; Haïk S; Cali I; Zhan Y; Moudjou M; Li B; Laplanche JL; Laude H; Langeveld J; Gambetti P; Kitamoto T; Kong Q; Brandel JP; Cobb BA; Petersen RB; Zou WQ
PLoS One; 2013; 8(3):e58786. PubMed ID: 23527023
[TBL] [Abstract][Full Text] [Related]
16. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle.
Kovacs GG; Lindeck-Pozza E; Chimelli L; Araújo AQ; Gabbai AA; Ströbel T; Glatzel M; Aguzzi A; Budka H
Ann Neurol; 2004 Jan; 55(1):121-5. PubMed ID: 14705121
[TBL] [Abstract][Full Text] [Related]
17. PrP(Sc) typing by N-terminal sequencing and mass spectrometry.
Chen SG; Zou W; Parchi P; Gambetti P
Arch Virol Suppl; 2000; (16):209-16. PubMed ID: 11214924
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity enhancement with chelators for increasing the detection sensitivity of human PrPSc by Western blotting.
Kuczius T; Brinkmann B; Grassi J
Neurochem Int; 2007 Jan; 50(1):102-8. PubMed ID: 16962685
[TBL] [Abstract][Full Text] [Related]
19. Mutagenesis studies in transgenic Xenopus intermediate pituitary cells reveal structural elements necessary for correct prion protein biosynthesis.
van Rosmalen JW; Martens GJ
Dev Neurobiol; 2007 May; 67(6):715-27. PubMed ID: 17443819
[TBL] [Abstract][Full Text] [Related]
20. PrP Sc-like prion protein conformer in sudden infant death syndrome brain.
Bergmann J; Bergmann R; Janetzky B; Singh S; Preddie E
Acta Neuropathol; 2004 Jan; 107(1):66-8. PubMed ID: 14605831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
